Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niclosamide Enemas in Active Ulcerative Proctitis or Procto-Sigmoiditis
NCT03521232Phase 2Terminated
- Sponsor
- Entero Therapeutics, Inc.
- Start
- May 2018
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niclosamide in ulcerative proctitis, ulcerative proctosigmoiditis, sponsored by Entero Therapeutics, Inc.. Started May 2018; status: terminated.
02
Drugs
niclosamide
03
Conditions
ulcerative proctitisulcerative proctosigmoiditis
Beyond the preview
Go deeper on NCT03521232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521232.